Aim and Scope

Aim & Scope

International Journal of NeuroOncology and Therapeutics (IJNOT) is an open-access, peer-reviewed journal dedicated to publishing cutting-edge research, clinical studies, and innovations in the field of neuro-oncology and neurological therapeutics. The journal provides a global platform for clinicians, neuroscientists, and oncology researchers to share evidence-based findings that enhance understanding, diagnosis, and treatment of tumors and diseases affecting the nervous system.

Its core mission is to bridge the gap between laboratory discovery and clinical application by promoting translational research that advances therapeutic strategies in neuro-oncology. The journal aims to foster scientific collaboration and innovation in areas such as targeted therapy, neuroimaging, molecular oncology, radiation biology, and personalized medicine—contributing to improved patient outcomes and global neuro-oncological care.

The journal welcomes contributions on a broad range of topics, including but not limited to:

• Brain and spinal cord tumors: biology, pathology, and genetics

• Translational and clinical neuro-oncology research

• Novel therapeutics including targeted, immune, and gene therapies

• Radiation oncology, radiosurgery, and advanced neuroimaging

• Neuropharmacology, molecular signaling, and tumor microenvironment

• Clinical trials, biomarkers, and precision oncology

• Neurosurgical oncology and minimally invasive techniques

• Neurotoxicology, rehabilitation, and survivorship studies

• Artificial intelligence, data analytics, and digital therapeutics

• Ethical, regulatory, and palliative care perspectives in neuro-oncology

We invite submissions in the form of original research papers, clinical case studies, review articles, and short communications. All manuscripts should aim to advance knowledge, innovation, and clinical practice in neuro-oncology and neurological therapeutics for the benefit of patients worldwide.